Viewing Study NCT03554161


Ignite Creation Date: 2025-12-24 @ 12:41 PM
Ignite Modification Date: 2026-01-09 @ 8:20 PM
Study NCT ID: NCT03554161
Status: TERMINATED
Last Update Posted: 2021-03-22
First Post: 2018-04-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Tocilizumab for the Treatment of Refractory Behcet's Uveitis
Sponsor: Wenjie Zheng
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module